Wells Fargo
ORGS

Wells Fargo’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Wells Fargo’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24
Closed -$199 – 7616
2024
Q1 		$199 Buy
24
+2
+9% +$11 ﹤0.01% 6496
2023
Q4 		$108 Buy
22
+3
+16% +$19 ﹤0.01% 6748
2023
Q3 		$120 Hold
19
– – ﹤0.01% 6721
2023
Q2 		$264 Buy
19
+3
+19% +$36 ﹤0.01% 6623
2023
Q1 		$194 Hold
16
– – ﹤0.01% 6782
2022
Q4 		$316 Buy
16
+1
+7% +$17 ﹤0.01% 6500
2022
Q3 		$0 Hold
15
– – ﹤0.01% 7577
2022
Q2 		$0 Buy
15
+2
+15% +$56 ﹤0.01% 7690
2022
Q1 		$0 Sell
13
-45
-78% -$1.37K ﹤0.01% 8025
2021
Q4 		$1K Hold
58
– – ﹤0.01% 7101
2021
Q3 		$3K Sell
58
-1
-2% -$50 ﹤0.01% 6516
2021
Q2 		$3K Sell
59
-14,400
-100% -$725K ﹤0.01% 6486
2021
Q1 		$829K Buy
14,459
+9,737
+206% +$634K ﹤0.01% 4374
2020
Q4 		$212K Buy
4,722
+412
+10% +$19.9K ﹤0.01% 5060
2020
Q3 		$217K Buy
4,310
+1,134
+36% +$61.5K ﹤0.01% 4922
2020
Q2 		$194K Buy
3,176
+3,168
+39,600% +$192K ﹤0.01% 4931
2020
Q1 		$0 Sell
8
-392
-98% -$17.1K ﹤0.01% 6958
2019
Q4 		$19K Hold
400
– – ﹤0.01% 5759
2019
Q3 		$18K Hold
400
– – ﹤0.01% 5830
2019
Q2 		$18K Buy
400
+200
+100% +$9.02K ﹤0.01% 5804
2019
Q1 		$11K Hold
200
– – ﹤0.01% 5629
2018
Q4 		$9K Buy
+200
New +$11.5K ﹤0.01% 5963

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wells Fargo's ORGS Position: Q2 2024 in Review

Wells Fargo sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2024, closing a stake of 24 shares — an estimated $199 sold.

Wells Fargo first reported a position in ORGS in Q4 2018 and held it in 22 quarters. The position peaked at $829K in Q1 2021. 18 funds tracked by Wall St. Rank hold ORGS as of Q2 2024.

  • Wells Fargo reported no remaining Orgenesis Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 24 Orgenesis Inc. Common Stock shares in Q2 2024, an estimated $199.
  • Wells Fargo first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 22 quarters.
  • Wells Fargo's Orgenesis Inc. Common Stock position peaked at $829K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.